View Information Collection Request (ICR) Package

OMB Control No: 0920-1046	ICR Reference No: 202111-0920-005
Status: Historical Active	Previous ICR Reference No: 202009-0920-022
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1046
Title: National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/17/2022
Retrieve Notice of Action (NOA)	Date Received in OIRA: 11/18/2021
Terms of Clearance: Previous terms continue: Any changes to the instruments need to be submitted for OMB approval (either as revisions or non-substantive changes requests, depending on the nature and extent of the changes) prior to use.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2025	36 Months From Approved	03/31/2022
Responses	1,400	0	910
Time Burden (Hours)	1,228	0	764
Cost Burden (Dollars)	38,976	0	38,976

Abstract: CDC is required to monitor and evaluate processes and outcomes for the NBCCEDP. Recipients are required to report information to CDC to support these efforts. Based on the redesigned NBCCEDP under DP22-2202, CDC developed a logic model to illustrate the strategies and expected outcomes associated with the NBCCEDP over time (Attachment 3 – DP22-2202 NBCCEDP Logic Model). In contrast to DP17-1701, DP22-2202 has a stronger focus on selecting and engaging partners to support NBCCEDP implementation, including serving populations disproportionately burdened by breast and/or cervical cancer and tracking them through screening completion. As illustrated in the logic model, CDC anticipates that recipients’ implementation of the five strategies and activities described will result in several desired short-, intermediate-, and long-term outcomes, including increased breast and cervical screening rates. The logic model guided development of CDC’s NBCCEDP monitoring and evaluation plan, which includes evaluation questions and sub-questions that map to the proposed information collections (Attachment 4 – NBCCEDP Evaluation Question Matrix) to be addressed through systematic monitoring and evaluation of these key strategies and the primary outcome of screening rate changes over time. In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-2202) to continue this mission with a stronger focus on collaborating with other public health programs and community-based organizations to serve populations disproportionately burdened by breast and/or cervical cancer. Based on data collection conducted throughout DP17-1701 and consistent with programmatic changes, the information collection plan has also been revised to update existing and add new data collection instruments and integrate the previously approved MDEs into this single approval package to increase efficiency. DP22-2202 is expected to fund the same number of recipients (N=70).

Authorizing Statute(s): PL: Pub.L. 101 - 354 2 Name of Law: Breast and Cervical Cancer Prevention and Treatment Act of 2000
US Code: 42 USC 300k Name of Law: Breast and Cervical Cancer Mortality Prevention Act of 1990

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 40055	07/26/2021
30-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 63394	11/16/2021
Did the Agency receive public comments on this ICR? Yes

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	1,400	910	490
Annual Time Burden (Hours)	1,228	764	464
Annual Cost Burden (Dollars)	38,976	38,976	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Changing Forms

Short Statement: These revisions were made to improve data quality. Because revisions increased the number of questions in the annual survey, burden hours increased from 56 to 65 burden hours. Revisions to the clinic-level data collection did not result in increased burden; therefore, the estimated burden remains the same. The QPU is new and involves four annual submissions for all 70 recipients for a net increase of 104 estimated burden hours. The service delivery projection worksheet is also new and involves an annual submission for all 70 recipients for a net increase of 34 estimated burden hours. There were no changes to the MDEs; therefore, the estimated burden remains the same.

Annual Cost to Federal Government: $682,478

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Thelma Sims 4046394771

View ICR - OIRA Conclusion